Flavin Containing Monooxygenase 3 (FMO3) Peptide
FMO3
Reactivity: Human
Host: Synthetic
BP, WB, IHC
-
- Target See all FMO3 products
- FMO3 (Flavin Containing Monooxygenase 3 (FMO3))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-FMO3 antibody (Catalog #: ARP44434_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- FMO3 (Flavin Containing Monooxygenase 3 (FMO3))
- Background
-
FMO3 is involved in the oxidative metabolism of a variety of xenobiotics such as drugs and pesticides. It N-oxygenates primary aliphatic alkylamines as well as secondary and tertiary amines. It acts on TMA to produce TMA-N-oxide.
Alias Symbols: FMOII, MGC34400, dJ127D3.1, TMAU
Protein Size: 532 - Molecular Weight
- 59 kDa
- Gene ID
- 2328
- NCBI Accession
- NM_001002294, NP_001002294
- UniProt
- P31513
-
You are here:
